Possible New Alzheimer's Drug: Annovis Bio (ANVS)
b'Annovis Bio (ANVS) is developing a drug that improves cognition and motor function among patients with Alzheimer\\u2019s and Parkinson\\u2019s Diseases. Founder and CEO, Maria Maccecchini, discusses what separates the Annovis Bio treatment from other therapies. Annovis Bio\\u2019s stock hit an all-time high on May 25th and Maccecchini has a very positive outlook for the future of the drug and company. Tune in to find out more.'